MICELLAR MICROPARTICLES: A NOVEL APPROACH TO TOPICAL DRUG DELIVERY SYSTEM
Topical drug delivery system is defined as the pharmaceutical dosage form which when applied onto the skin provides protection of skin and prevents serious skin disorders. Topical drug are being used for several years and still have its potential in new pharmaceutical technologies investigated. Skin is the most easily accessible organ of the body which has the potential to facilitate the delivery of several drugs with better efficacy, confining the pharmacological or other effect of the drug to the surface of the skin. Micelles are colloidal particles with a size smaller than 100 nm that allow a great depth of tissue penetration for targeted drug delivery, but rapidly disintegrate in the body. Microparticles containing micelles have the potential for delivering hydrophobic drug encapsulated in micelles on the target site in the specific part of the body. Micellar microparticles allow the improvement of solubility and dissolution of poorly soluble drugs. Microparticles containing micelles have the potential for delivering micelle-encapsulated hydrophobic drugs in targeted therapy. This article reviews the topical drug delivery system, colloidal drug delivery system and aspects and literature reviewed on micellar microparticles and its advantages in pharmaceuticals. An overview of reviews was conducted to locate published literature between 2000 and 2017.Â
2. Sah SK, Badola A, Mukhopadhyay S. Development and evaluation of tioconazole loaded emulgel. Int J Appl Pharm 2017;9:83-90.
3. Chang RK, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. Am Assoc Pharm Sci J 2013;15:41-52.
4. Tadwee IK, Gore S, Giradkar SP. Advances in topical drug delivery system: a review. Int J Pharm Res Appl sci 2011;1:14-23.
5. Kumar KK, Sasikanth K, Sabareesh M, Dorababu N. Formulation and evaluation of diacerein cream. Asian J Pharm Clin Res 2011;4:93-8.
6. Shaikh AC, Quazi A, Nazim S, Majaz Q, Siraj S, Khan T, et al. Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride. Asian J Pharm Clin Res 2011;4:61-70.
7. Sruthi TP, Noby T, Daisy PA, Carla B. Microsponge drug delivery system for topical delivery-a review. Int J Pharm Chem Biol Sci 2016;6:424-31.
8. Sah S, Badola A, Nayak B. Emulgel: magnifying the application of topical drug delivery. Ind J Pharm Biol Res 2017;5:25-33.
9. Kshirsagar N. Drug delivery systems. Indian J Pharmacol 2000;32:S54-S61.
10. Zi P, Yang X, Kuang H, Yang Y, Yu L. Effect of HPbeta CD on solubility and transdermal delivery of capsaicin through rat skin. Int J Pharm 2008;358:151-8.
11. Rathbone M, Hadgraft J, Roberts M, Lane M. Dermal and transdermal drug delivery. Modified-release drug delivery technology. 2nd ed. U. K. Informa healthcare; 2002. p. 263-71.
12. Date A, Naik B, Nagarsenker M. Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006;19:2-16.
13. Foldvari M. Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm Sci Technol Today 2000;3:417-25.
14. Elsayed M, Abdallah O, Naggar V, Khalafallah N. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1-16.
15. Dhote V, Bhatnagar P, Mishra PK, Mahajan SC, Mishra DK. Iontophoresis: a potential emergence of a transdermal drug delivery system. Sci Pharm 2012;80:1-28.
16. Garg T, Rath G, Goyal AK. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Delivery 2014;22:969-87.
17. Nair A, Jacob S, Al-Dhubiab B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Braz J Pharm Sci 2013;49:423-34.
18. Zhang Q, Grice JE, Wang G, Roberts MS. Cutaneous metabolism in transdermal drug delivery. Curr Drug Metab 2009;10:227-35.
19. Fox LT, Gerber M, Du Plessis J, Hamman JH. Transdermal drug delivery enhancement by compounds of natural origin. Molecules 2011;16:10507-40.
20. Tadwee IK, Gore S, Giradkar SP. Advances in topical drug delivery system: a review. Int J Pharm Res Appl Sci 2011;1:14-23.
21. Kikwai L, Babu RJ, Prado R, Kolot A, Armstrong CA, Ansel JC, et al. In vitro and in vivo evaluation of topical formulations of spantide II. AAPS Pharm Sci Tech 2005;6:565-72.
22. Moshfeghi AA, Peyman GA. Micro-and nanoparticulates. Adv Drug Delivery Rev 2005;57:2047-52.
23. Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discovery 2005;4:381-5.
24. Zi P, Yang X, Kuang H, Yang Y, Yu L. Effect of HPbeta CD on solubility and transdermal delivery of capsaicin through rat skin. Int J Pharm 2008;358:151-8.
25. Rathbone M, Hadgraft J, Roberts M, Lane M. Dermal and transdermal drug delivery. Modified-release drug delivery technology. 2nd ed. U. K. Informa healthcare; 2002. p. 263-71.
26. Ajazuddin A, Alexander A, Khichariya S, Gupta RJ, Patel TK. Recent expansions in an emergent novel drug delivery technology: Emulgel. J Controlled Release 2013;171:122-32.
27. Yousef H, Sharma S. Anatomy, skin (Integument), Epidermis. Treasure Island (FL): Stat Pearls Publishing; 2018.
28. Wickett RR, Visscher MO. Structure and function of the epidermal barrier. Am J Infect Controlled 2006;34:S98-S110.
29. Dev A, Chodankar R, Shelke O. Emulgels: a novel topical drug delivery system. Pharma Bio Eval 2015;2:64-75.
30. Panwar S, Upadhyay N, Bairagi M, Gujar S, Darwhekar GN, Jain DK. Emulgel: a review. Asian J Pharm Life Sci 2011;1:333-42.
31. Dadwal M. Emulgel: a novel approach to topical drug delivery. Int J Pharm Bio Sci 2013;4:847-56.
32. Kute SB, Saudagar RB. Emulsified gel a novel approach for delivery of hydrophobic drugs: an overview. J Adv Pharm Edu Res 2013;3:368-76.
33. Khullar R, Saini S, Seth N, Rana AC. Emulgels: a surrogate approach for topically used hydrophobic drugs. Int J Pharm Bio Sci 2011;1:117-28.
34. Waugh A, Grant A. Ross and Wilson: anatomy and pharmacology in health and illness. Churchill Living stone; 2004. p. 361-4.
35. Rieger MM, Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. PA Lea and Febiger, Philadelphia; 1986. p. 502-33.
36. Ruela ALM, Perissinato AG, Lino MES, Mudrik PS, Pereira GR. Evaluation of skin absorption of drugs from topical and transdermal formulations. Braz J Pharm Sci 2016;52:527-44.
37. Singh MD, Mital N, Kaur G. Topical drug delivery systems: a patent review. Expert Opin Ther Pat 2016;26:213-28.
38. Lachman L, Lieberman HA, Kang JL. Theory and practice of industrial pharmacy. Bombay, India: Verghese Publishing House; 1991. p. 534-63.
39. Lu PJ, Weitz DA. Colloidal particles: crystals, glasses, and gels. Annu Rev Condens Matter Phys 2013;4:217-33.
40. Sharma J, Kalra S, Sharma A, Rani S. Colloidal drug carriers. J Fam Pract 2009;9:21-37.
41. Vyas A, Kumar SA, Gidwani B. Carrier-based drug delivery system for the treatment of acne. Sci World J 2014:1-14. http://dx.doi.org/10.1155/2014/276260
42. Kevin L, Helen B. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 2007;65:259-69.
43. Husseini GA, Pitt WG. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Delivery Rev 2008;60:1137-52.
44. Markus J, Per H, Katarina E. Spherical micelles and other self-assembled structures in dilute aqueous mixtures of poly (Ethylene Glycol) lipids. J Phys Chem B 2001;105:8420-30.
45. Shota F, Shimpei Y, Sakiko M, Genki K, Kenta Y, Eri T, et al. Platonic micelles: monodisperse micelles with discrete aggregation numbers corresponding to regular polyhedra. Sci Rep. 2017;7:44494.
46. Lombardo D, Calandra P, Barreca D, MagazÃ¹ S, Kiselev M. Soft interaction in liposome nanocarriers for therapeutic drug delivery. J Nanomater 2016;6:125.
47. Pelizzetti E, Pramauro E. Analytical applications of organized molecular assemblies. Anal Chim Acta 1985;169:1-29.
48. Hofland HEJ, Bouwstra JA, Spies F, Bodde HE, Nagelkerke JF, Cullander C. Interactions between non-ionic surfactant vesicles and human stratum corneum in vitro. J Liposome Res 1995;5:241-63.
49. Abraham W, Downing DT. Interaction between corneocytes and stratum corneum lipid liposomes in vitro. Biochim Biophys Acta 1990;1021:119-25.
50. Zellmer S, Pfeil W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1995;1237:176-82.
51. Coderch L, Fonollosa J, De Pera M, Estelrich J, De La Maza A, Parra JL. Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. J Controlled Release 2000;68:85-95.
52. Mezei M, Gulasekharam V. Liposomesâ€“a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26:1473-7.
53. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473-4.
54. Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 1990;7:479-89.
55. Bilgicer B. Biomedical Engineering; 2009.
56. Aliabadi H, Lavasaniafar A. Polymeric micelles for the drug delivery. Expert Opin Drug Delivery 2006;3:139-62.
57. Hinze WL, Pramauro E. A critical review of surfactant-mediated phase separations (cloud point extractions)-theory and applications. Crit Rev Anal Chem 1993;24:133-77.
58. Pereira MG, Arruda MAZ. Trends in pre-concentration procedures for metal determination using atomic spectrometry techniques. Microchim Acta 2003;141:115-31.
59. Opanasopit P, Yokoyama M, Watanabe M, Kawano K, Maitani Y, Okano T. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004;21:2001-8.
60. Cai S, Vijayan K, Cheng D, Lima EM, Discher DE. Micelles of different morphologies-advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery. Pharm Res 2007;24:2099-109.
61. Hofman JW, Carstens MG, Van Zeeland F, Helwig C, Flesch FM, Hennink WE. Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation. Pharm Res 2008;25:2065-73.
62. Vakil R, Knilans K, Andes D, Kwon GS. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles. Pharm Res 2008;25:2056-64.
63. Yang Y, Chen C, Yang J, Tsai T. Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin. AAPS J 2010;12:138-46.
64. Jette KK, Law D, Schmitt EA, Kwon GS. Preparation and drug loading of poly (ethylene glycol)-block-poly (Îµcaprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharm Res 2004;21:1184-91.
65. Djordjevic J, Barch M, Uhrich KE. Polymeric micelles based on amphiphilic scorpion-like macromolecules: novel carriers for water-insoluble drugs. Pharm Res 2005;22:24-32.
66. Mourya VK, Inamdar N, Nawale RB, Kulthe SS. Polymeric micelles: general considerations and their applications. Ind J Pharm Edu Res 2011;45:128-38.
67. Fournier E, Dufresne MH, Smith DC, Ranger M, Leroux JC. A novel one-step drug-loading procedure for water soluble amphiphilic nanocarriers. Pharm Res 2004;21:962-8.
68. Liu B, Yang M, Li R, Ding Y, Qian X, Yu L, Jiang X. The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm 2008;69:527-34.
69. Qiu LY, Zhang JX, Yan MQ, Jin Y, Zhu KJ. Reverse self-assemblies based on amphiphilic polyphosphazenes for encapsulation of water-soluble molecules. Nanotech 2007;18:475-602.
70. Yang Y, Chen C, Yang J, Tsai T. Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin. AAPS J 2010;12:138-46.
71. Maheswari PD, Rambhau D, Narasu ML. Microparticles-entrapped micelles: a novel delivery system to improve solubility and dissolution rate of poorly water-soluble valsartan. J Microencapsul 2013;30:805-16.
72. Maheswari PD, Rambhau D, Narasu ML. Micellar solubilization in the formulation development of poorly soluble naproxen. Pharm Reg Affairs 2013;2:108.
73. Tran QT, Vu THM, Tran VT. Preparation of 200 mg fenofibrate hard capsule with high dissolution profile with microparticle entrapped micelles technology. J Pharm Sci 2017;44:50-7.